All Antimicrobials articles
-
NewsAncient, insect-targeting bacterial toxin may have implications for human health, agriculture, and drug discovery
Scientists have identified and characterized a new class of Streptomyces-produced toxins that are very distantly related to the deadly toxin that causes diphtheria, a serious and contagious infection, in humans.
-
NewsNew study suggests seasonal flu vaccines may reduce severity of H5N1 bird flu infections
Researchers have found that seasonal influenza vaccines in routine global use may significantly reduce the risk of death from H5N1 infection. The findings that readily available tools may offer protection while the world races to develop more targeted solutions.
-
NewsEight-year results from two randomized phase 3 trials of tenofovir alafenamide for chronic hepatitis B virus infection in China
Tenofovir alafenamide (TAF) has demonstrated comparable efficacy to tenofovir disoproxil fumarate (TDF), with improved renal and bone safety, in Chinese participants with chronic hepatitis B enrolled in two Phase 3 trials.
-
NewsScientists catch a fungal enzyme open for business
A new study shows that caspofungin, a widely used antifungal drug, works only when its target enzyme is active, pointing the way toward designing better treatments.
-
NewsNasal spray could transform treatment of deadly cerebral malaria
Master’s student Taznita Kista is exploring whether a nano-enabled nasal spray could change how cerebral malaria is treated. Her work focuses on a nose-to-brain drug delivery system using niosomes.
-
NewsNew lactic acid bacteria for plant-based yogurt alternatives
Researchers find that a particular type of lactic acid bacteria has considerable potential for producing plant-based yoghurt alternatives. The bacteria inhibit potentially harmful bacteria and break down sugars that can cause stomach discomfort.
-
NewsCDI breakthroughs lead to new drug development deal for deadly NTM bacteria
Scientists have developed new compounds against non-tuberculous mycobacteria which are now the subject of a new collaboration and license agreement with the Switzerland-based and publicly listed BioVersys AG.
-
NewsEarly immune responses linked to protective HIV antibodies
In a new study of broadly neutralizing antibodies and their potential for an HIV vaccine, researchers analyzed fragments of cell-free RNA and DNA circulating in the blood. This makes it possible to track immune responses, viral genetic variation, and other microbes from the same blood sample.
-
NewsMillions suffering needlessly with curable hepatitis C, new analysis reveals
Millions of Americans are still battling potentially deadly hepatitis C even though they could be cured with antiviral drugs they are not receiving, a new analysis reveals.
-
NewsPlastic texturing kills viruses when they land
Researchers have developed a thin plastic film that tears apart viruses on contact, offering a promising new way to keep high touch surfaces such as smartphones and hospital equipment from spreading disease.
-
NewsNew biodegradable wash removes pesticides and extends produce shelf life
Researchers have developed a natural, biodegradable wash that removed up to 96 per cent of pesticide residue from fruit and slowed browning and moisture loss.
-
NewsScientists discover the antibacterial potential of ‘hero’ Korean skincare ingredient
Fans of Korean skincare may be familiar with ‘hero ingredient’ Madecassic acid for its skin-soothing properties, but researchers have revealed its greater potential for use in the battle against antibiotic resistance.
-
NewsBelfast to host global scientists at the Microbiology Society’s Annual Conference 2026
Baroness Natalie Bennett will join leading scientists and policymakers in Belfast for a discussion on how to slow the spread of superbugs at the Microbiology Society’s Annual Conference.
-
NewsTurmeric/ginger extract shows multiple benefits for bone implants
An extract of turmeric and ginger helps bone implants bond strongly while killing bacteria and cancer cells, according to new research with implications for millions of patients with joint replacements and bone cancer.
-
NewsOregano, rosemary and ‘time’: Long-term swine study shows natural-compound benefits
In a rare long-term public study that compared the effects of phytochemicals from rosemary and oregano with antibiotic growth promoters, animal scientists found that the natural agents given to weaned pigs supported favorable gut health and growth performance later in their lives.
-
NewsScientists warn antibacterial soaps and wipes can fuel antimicrobial resistance
An international team of scientists is warning that everyday antibacterial soaps, wipes, sprays, and other “germ‑killing” products are quietly contributing to the global rise of antimicrobial resistance (AMR) while providing no added health benefit for most consumer uses.
-
NewsNew antibiotic alternative fights foodborne salmonella
Researchers have discovered a safe and highly effective natural virus that functions like a precision-guided missile, capable of eliminating harmful Salmonella on various foods and packaging materials, showing great potential as a novel guardian for food safety.
-
NewsDramatic reduction in prescribing of hepatitis C antivirals may leave many curable patients untreated
A new study analyzed a large national prescription database to estimate hepatitis C treatment courses over time and trends by patient and prescriber characteristics from 2013–2025. Prescriptions rose rapidly after direct-acting antivirals first became available, peaking in 2015, but then declined sharply through 2025.
-
NewsMachine learning identifies antimicrobial peptide candidate for ulcerative colitis
Scientists applied machine learning to accelerate AMP discovery and identify candidates with therapeutic potential for ulcerative colitis.
-
NewsWhy some people naturally control HIV even after stopping therapy — and how we can leverage that to treat others
New research offers a path toward life without daily HIV pills, suggesting a common diabetes pill could help achieve long-term remission.